{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:39:19Z","timestamp":1778243959851,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Government (ISCIII-FEDER)","award":["PI14\/02070"],"award-info":[{"award-number":["PI14\/02070"]}]},{"name":"Spanish Government (ISCIII-FEDER)","award":["PI17\/01931"],"award-info":[{"award-number":["PI17\/01931"]}]},{"name":"Fundaci\u00f3n Gangoiti"},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.nbd.2018.06.019","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T18:14:27Z","timestamp":1529604867000},"page":"64-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing\/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia"],"prefix":"10.1016","volume":"118","author":[{"given":"Estefania","family":"Rojo-Bustamante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Abellanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Clavero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Thiolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosario","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-1538","authenticated-orcid":false,"given":"Maria S.","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.06.019_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1460-9568.2008.06551.x","article-title":"Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity","volume":"29","author":"Adermark","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s12035-014-8688-7","article-title":"Sustained increase of PKA activity in the Postcommissural putamen of Dyskinetic monkeys","volume":"50","author":"Azkona","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0020","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0030","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1523\/JNEUROSCI.17-04-01226.1997","article-title":"Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain","volume":"17","author":"Cadas","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.06.019_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2016.06.010","article-title":"Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease","volume":"57","author":"Celorrio","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2018.06.019_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of parkinsonism? Chronic treatment with L-Dopa","volume":"280","author":"Cotzias","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2018.06.019_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.06.019_bb0055","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuroscience.2007.11.047","article-title":"Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain","volume":"151","author":"Cristino","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.06.019_bb0065","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2018.06.019_bb0070","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.06.019_bb0075","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1096\/fasebj.14.10.1432","article-title":"Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease","volume":"14","author":"Di Marzo","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2018.06.019_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2016.06.013","article-title":"Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action","volume":"94","author":"dos-Santos-Pereira","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.06.019_bb0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/cne.21568","article-title":"Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules","volume":"506","author":"Egertov\u00e1","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0090","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/cercor\/bhu076","article-title":"Widespread Monoaminergic dysregulation of both motor and non-motor circuits in parkinsonism and dyskinesia","volume":"25","author":"Engeln","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2018.06.019_bb0095","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB2 receptor: a new target for controlling neural cell survival?","volume":"28","author":"Fern\u00e1ndez-Ruiz","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/NEN.0b013e3182717cba","article-title":"Loss of Parvalbumin-positive neurons from the Globus Pallidus in animal models of Parkinson disease","volume":"71","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0110","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/mds.10289","article-title":"Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease","volume":"17","author":"Fox","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.06.019_bb0115","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.23829","article-title":"The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease","volume":"26","author":"Fox","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.06.019_bb0120","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2018.06.019_bb0125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/bph.13215","article-title":"Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia","volume":"173","author":"Garc\u00eda","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0135","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","article-title":"Postsynaptic endocannabinoid release is critical to long-term depression in the striatum","volume":"5","author":"Gerdeman","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0140","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB 2 receptor as a pharmacological target against inflammation in Parkinson's disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.06.019_bb0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.nbd.2013.10.008","article-title":"Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson's disease","volume":"62","author":"Gonz\u00e1lez-Aparicio","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.06.019_bb0150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0155","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1523\/JNEUROSCI.4159-06.2007","article-title":"Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the Hippocampus","volume":"27","author":"Hashimotodani","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0160","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00702-003-0033-7","article-title":"Expression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain","volume":"110","author":"Hurley","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2018.06.019_bb0165","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1523\/JNEUROSCI.0309-06.2006","article-title":"Molecular composition of the endocannabinoid system at glutamatergic synapses","volume":"26","author":"Katona","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.06.019_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000709","article-title":"Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex","volume":"2","author":"Lafourcade","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.06.019_bb0180","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","article-title":"Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets","volume":"14","author":"Lastres-Becker","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nimg.1996.0036","article-title":"A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy","volume":"4","author":"Martin","year":"1996","journal-title":"NeuroImage"},{"key":"10.1016\/j.nbd.2018.06.019_bb0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nbd.2014.11.024","article-title":"Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats","volume":"74","author":"Martinez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.06.019_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and Monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2018.06.019_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2006.07.004","article-title":"The globus pallidus pars externa and Parkinson's disease. Ready for prime time?","volume":"202","author":"Obeso","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.06.019_bb0215","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/cbdv.200790155","article-title":"Biosynthetic pathways of the Endocannabinoid Anandamide","volume":"4","author":"Okamoto","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.nbd.2018.06.019_bb0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2018.06.019_bb0225","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrn2915","article-title":"Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease","volume":"11","author":"Redgrave","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fninf.2012.00027","article-title":"The INIA19 template and NeuroMaps atlas for primate brain image parcellation and spatial normalization","volume":"6","author":"Rohlfing","year":"2012","journal-title":"Front. Neuroinform."},{"key":"10.1016\/j.nbd.2018.06.019_bb0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0024-3205(99)00618-9","article-title":"Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen","volume":"66","author":"Romero","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012322","article-title":"Distinct changes in cAMP and extracellular signal- regulated protein kinase Signalling in L-DOPA-induced dyskinesia","volume":"5","author":"Santini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.06.019_bb0245","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","article-title":"Motor actions of cannabinoids in the basal ganglia output nuclei","volume":"65","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2018.06.019_bb0250","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.57.11.2108","article-title":"Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study","volume":"57","author":"Sieradzan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.06.019_bb0255","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.06.019_bb0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2018.06.019_bb0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.06.019_bb0270","doi-asserted-by":"crossref","first-page":"620.e1","DOI":"10.1016\/j.neurobiolaging.2011.02.009","article-title":"Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo","volume":"33","author":"Van Laere","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2018.06.019_bb0275","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.brainresbull.2010.01.009","article-title":"Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat","volume":"81","author":"Walsh","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2018.06.019_bb0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00762-4","article-title":"Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats","volume":"276","author":"Zeng","year":"1999","journal-title":"Neurosci. Lett."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118301979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118301979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T03:49:15Z","timestamp":1604461755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118301979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":56,"alternative-id":["S0969996118301979"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.06.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing\/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}